Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Nvidia (NVDA) on Friday disclosed a nearly $21 billion stake in Elon Musk’s SpaceX and a $30 billion one in Intel Corp.The AI chipmaking giant had about 122.8 million shares in SpaceX as of June 30, according to a regulatory filing made Friday. It held about 214.8 million in Intel.
- Alibaba Group Holding (BABA) is selling its gaming arm in a deal worth at least $1.5 billion that will boost the Chinese e-commerce leader’s pivot to AI. Asian private equity firm Trustar Capital has reached an agreement to acquire Lingxi Games, according to an internal memo distributed on Monday and reviewed by Bloomberg News. “Alibaba is handing Lingxi to Trustar due to better focus on its strategic priorities,” said Zhou Bingshu, chief executive officer of Lingxi Games, without disclosing the size of the deal.
- Ferrari's (RACE) first all-electric vehicle defied criticism to sell for $40 million, making it the most expensive new car ever sold at auction.The Sotheby’s charity auction of the “tailor-made” Luce at Monterey Car Week in California over the weekend broke a record posted last year, when Ferrari’s customized Daytona SP3 sold for $26 million, the carmaker said in a statement. The buyer wasn’t identified.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Fresnillo shares rise alongside other British mining companies as copper advances towards a record, with a key spread in London widening to extreme levels in a sign of competition for prompt supply.
- AstraZeneca shares rise as much as 1.4% after the pharmaceutical giant said it is stopping a clinical trial of the experimental drug volrustomig, which didn’t look set to help fight lung cancer better than existing therapies.
- Argenx shares jump as much as 10%, the most in more than a year, after the company announced positive late-stage trial results for its experimental myositis treatment.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AstraZeneca shares rise after the pharmaceutical giant said it is stopping a clinical trial of the experimental drug volrustomig after it didn’t look set to help fight lung cancer better than existing therapies.

- Glencore shares rise after Export-Import Bank of Korea announced it will lend $1 billion to the commodities giant in exchange for copper supply to South Korean companies, as the country seeks to secure raw materials needed for the artificial intelligence boom.

- Argenx jumps as much as 10%, the most in more than a year, after the company announced positive late-stage trial results for its experimental myositis treatment.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Kioxia shares rise after a boost in demand for AI related stocks, as Anthropic tells prospective investors that its second-quarter revenue jumped at least 14-fold versus the same period a year ago.

- Leveraged Samsung shares rise alongside other leveraged ETFs listed in Hong Kong, after investors pile into more risky bets as South Korean markets remain closed today.

- Alibaba shares rise as much as 2.5% after the e-commerce giant disclosed a deal to sell its gaming arm and touted claims of more than 3 billion downloads for its open AI model.
See omnystudio.com/listener for privacy information.

Earnings are in focus with Target, Walmart and Deere reporting in the coming days.

Bloomberg’s Nathan Hager previews what to expect from these companies in the week ahead with Avalon Pernell, Bloomberg News Equities Reporter.
See omnystudio.com/listener for privacy information.